Maurer Lisa K, Maurer Heiko, König Manuel, van Munster Marlena, Haen Saskia, Pedrosa David J
Neuromotor Behavior Laboratory, Department of Psychology and Sport Science, Justus Liebig University Giessen, Germany.
Center for Mind, Brain and Behavior, Universities of Marburg, Giessen and Darmstadt, Germany.
Clin Park Relat Disord. 2024 Nov 26;11:100290. doi: 10.1016/j.prdoa.2024.100290. eCollection 2024.
Parkinson's disease (PD) often leads to gait abnormalities, increasing the risk of falls and affecting daily life. Sensorimotor insoles aim to enhance foot sensitivity, potentially improving gait stability.
This study examined whether there are short-term effects of sensorimotor insoles on neural activation (measured by EEG), kinematic gait parameters (speed, cadence, step length, and step-length variability), and subjective gait stability in PD patients. Sixteen individuals suffering from PD completed a gait task while wearing sensorimotor and placebo insoles, respectively.
The results showed no significant changes in kinematic parameters with the sensorimotor insoles. Subjective ratings of gait stability and attentional control of gait improved on average with the sensorimotor insoles, but again did not reach statistical significance. There was no significant reduction in alpha-band activity, indicating no improvement in sensorimotor processing.
The immediate impact of sensorimotor insoles on sensorimotor processing and gait characteristics in PD patients remains inconclusive. The small sample size limited the statistical power, highlighting the need for larger studies to comprehensively assess efficacy. Further research should investigate the long-term effects and potential benefits on disability measures in PD patients.
帕金森病（PD）常导致步态异常，增加跌倒风险并影响日常生活。感觉运动鞋垫旨在增强足部敏感性，可能改善步态稳定性。
本研究调查了感觉运动鞋垫对帕金森病患者神经激活（通过脑电图测量）、运动步态参数（速度、步频、步长和步长变异性）以及主观步态稳定性是否有短期影响。16名帕金森病患者分别穿着感觉运动鞋垫和安慰剂鞋垫完成一项步态任务。
结果显示，使用感觉运动鞋垫后运动学参数无显著变化。感觉运动鞋垫使步态稳定性的主观评分和步态注意力控制平均有所改善，但同样未达到统计学显著性。α波活动没有显著降低，表明感觉运动处理没有改善。
感觉运动鞋垫对帕金森病患者感觉运动处理和步态特征的即时影响仍无定论。样本量小限制了统计功效，凸显了开展更大规模研究以全面评估疗效的必要性。进一步的研究应调查对帕金森病患者残疾指标的长期影响和潜在益处。
